Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 4302O

GlaxoSmithKline PLC

04 November 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Dr M M Slaoui

Position/status

Chairman, Global Vaccines

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

An increase of 22 ADS following the notional allocation of ADSs on 3 November 2016, at a price of $38.74 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

Price(s) and volume(s)

Price(s)	Volume(s)
$38.74	22

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-11-03

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Dr K Slaoui

Position/status

PCA of Dr M M Slaoui (Chairman, Global Vaccines)

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

An increase of 3 ADS following the notional allocation of ADSs on 3 November 2016, at a price of $38.74 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

Price(s) and volume(s)

Price(s)	Volume(s)
$38.74	3

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-11-03

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDZLFBQFFFFBF

RNS metadata

Title: Director/PDMR Shareholding
Time: 17:12:50
Date: 4 Nov 2016
Category: Director/PDMR dealings
ID: 4302O